Linzhang Huang

Linzhang Huang

Auto-generated profile, based on publicly available information

Linzhang Huang

State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Drug Clinical Trial Center, Shanghai Xuhui Central Hospital/Xuhui Hospital, Fudan University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in Nature
Verified
Journal Article
Closed access
PDF file
LHLinzhang Huang
Linzhang Huang
KCKen L. Chambliss
Ken L. Chambliss
XGXiaofei Gao
Xiaofei Gao
IYIvan S. Yuhanna
Ivan S. Yuhanna
EBErica Behling-Kelly
Erica Behling-Kelly
PSPhilip W. Shaul
Philip W. Shaul

1 January 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LHLin-Zhang Huang
Lin-Zhang Huang
BHBao-Kang Huang
Bao-Kang Huang
QYQi Ye
Qi Ye
LQLu-Ping Qin
Lu-Ping Qin

15 March 2016 in Science Signaling
Verified
Journal Article
Closed access
PDF file
YDYinyuan Ding
Yinyuan Ding
LHLinzhang Huang
Linzhang Huang
XXXunde Xian
Xunde Xian
IYIvan S. Yuhanna
Ivan S. Yuhanna
CWCatherine R. Wasser
Catherine R. Wasser
JHJoachim Herz
Joachim Herz
The multimodular glycoprotein Reelin controls neuronal migration and synaptic transmission by binding to apolipoprotein E receptor 2 (Apoer2) and very low density lipoprotein receptor (Vldlr) on neurons. In the periphery, Reelin is produced by the liver, circulates in blood, and promotes thrombosis and hemostasis. To investigate if Reelin influences atherogenesis, we studied atherosclerosis-prone low-density lipoprotein receptor–deficient (Ldlr−/−) mice in which we inducibly deleted Reelin either ubiquitously or only in the liver, thus preventing the production of circulating Reelin. In both types of Reelin-deficient mice, atherosclerosis progression was markedly attenuated, and macrophage content and endothelial cell staining for vascular cell adhesion molecule–1 (VCAM-1) and intercellular adhesion molecule–1 (ICAM-1) were reduced at the sites of atherosclerotic lesions. Intravital microscopy revealed decreased leukocyte-endothelial adhesion in the Reelin-deficient mice. In cultured human endothelial cells, Reelin enhanced monocyte adhesion and increased ICAM1, VCAM1, and E-selectin expression by suppressing endothelial nitric oxide synthase (eNOS) activity and increasing nuclear factor κB (NF-κB) activity in an Apoer2-dependent manner. These findings suggest that circulating Reelin promotes atherosclerosis by increasing vascular inflammation, and that reducing or inhibiting circulating Reelin may present a novel approach for the prevention of cardiovascular disease.

1 May 2015 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
LHLinZhang Huang
LinZhang Huang
BFBao Yan Fan
Bao Yan Fan
AMAng Ma
Ang Ma
PSPhilip W. Shaul
Philip W. Shaul
HZHaibo Zhu
Haibo Zhu
ATP-Binding Cassette Transporter A1 (ABCA1) plays a key role in the initial lipidation of apoA-I, which generates circulating HDL cholesterol. Whereas it is known that the transcriptional upregulation of ABCA1 promotes HDL formation and reverse cholesterol transport (RCT), it is not known how the inhibition of ABCA1 protein degradation impacts HDL function. Employing the small molecule IMM-H007, we determined how the attenuation of ABCA1 protein degradation affects HDL cholesterol efflux capacity, RCT and atherosclerotic lesion formation. Pulse-chase analysis revealed that IMM-H007 inhibits ABCA1 degradation and facilitates its cell-surface localization in macrophages, and additional studies in macrophages showed that IMM-H007 thereby promotes cholesterol efflux. IMM-H007 treatment of Paigen diet-fed mice caused an increase in circulating HDL level, it increased the cholesterol efflux capacity of HDL, and it enhanced in vivo RCT from macrophages to the plasma, liver, and feces. Furthermore, ABCA1 degradation suppression by IMM-H007 reduced atherosclerotic plaque formation in apoE-/- mice. Thus, via effects on both ABCA1-expressing cells and circulating HDL function, the inhibition of ABCA1 protein degradation by IMM-H007 promotes HDL cholesterol efflux capacity and RCT and attenuates atherogenesis. IMM-H007 potentially represents a lead compound for the development of agents to augment HDL function.

25 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LYLiming Yu
Liming Yu
Lin XuLin Xu
Lin Xu
HCHaiyan Chu
Haiyan Chu
JPJun Peng
Jun Peng
ASAnastasia Sacharidou
Anastasia Sacharidou
PSPhilip W. Shaul
Philip W. Shaul
Hypercholesterolemia and vascular inflammation are key interconnected contributors to the pathogenesis of atherosclerosis. How hypercholesterolemia initiates vascular inflammation is poorly understood. Here we show in male mice that hypercholesterolemia-driven endothelial activation, monocyte recruitment and atherosclerotic lesion formation are promoted by a crosstalk between macrophages and endothelial cells mediated by the cholesterol metabolite 27-hydroxycholesterol (27HC). The pro-atherogenic actions of macrophage-derived 27HC require endothelial estrogen receptor alpha (ERα) and disassociation of the cytoplasmic scaffolding protein septin 11 from ERα, leading to extranuclear ERα- and septin 11-dependent activation of NF-κB. Furthermore, pharmacologic inhibition of cyp27a1, which generates 27HC, affords atheroprotection by reducing endothelial activation and monocyte recruitment. These findings demonstrate cell-to-cell communication by 27HC, and identify a major causal linkage between the hypercholesterolemia and vascular inflammation that partner to promote atherosclerosis. Interventions interrupting this linkage may provide the means to blunt vascular inflammation without impairing host defense to combat the risk of atherosclerotic cardiovascular disease that remains despite lipid-lowering therapies.

1 February 2011 in Die Pharmazie
Verified
Journal Article
Closed access
LHLinzhang Huang
Linzhang Huang
HZHongfang Zhao
Hongfang Zhao
BHBaokang Huang
Baokang Huang
CZChengjian Zheng
Chengjian Zheng
WPWei Peng
Wei Peng
LQLuping Qin
Luping Qin
Acanthopanax senticosus (Rupr. et Maxim) Harms (Araliaceae), also called Siberian Ginseng, Eleutherococcus senticosus, and Ciwujia in Chinese, is a widely used traditional Chinese herb that could invigorate qi, strengthen the spleen, and nourish kidney in the theory of Traditional Chinese Medicine. With high medicinal value, Acanthopanax senticosus (AS, thereafter) is popularly used as an "adaptogen" like Panax ginseng. In recent decades, a great number of chemical, pharmacological, and clinical studies on AS have been carried out worldwide. Several kinds of chemical compounds have been reported, including triterpenoid saponins, lignans, coumarins, and flavones, among which, phenolic compounds such as syringin and eleutheroside E, were considered to be the most active components. Considerable pharmacological experiments both in vitro and in vivo have persuasively demonstrated that AS possessed anti-stress, antiulcer, anti-irradiation, anticancer, anti-inflammatory and hepatoprotective activities, etc. The present review is an up-to-date and comprehensive analysis of the botany, chemistry, pharmacology, toxicity and clinical trials of AS.